Results 21 to 30 of about 10,565 (202)

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas [PDF]

, 1996
This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas.
W. J. Edmunds, G. F. Medley, D. J. Nokes, C. J. O'Callaghan, H. C. Whittle, A. J. Hall, Reniers, Sokal, Pearce, Tong, Pongpipat, Gebreselassie, Overby, Prozesky, Swenson, Anderson, Milne, Sobeslavsky, Schweitzer, Shiraki, Barin   +20 more
core   +1 more source

GAMBARAN ANTI HBc POSITIF PADA DONOR DARAH DENGAN HbsAG NEGATIF

Majalah Kedokteran Andalas, 2009
AbstrakPemeriksaan HBsAg saja untuk skrining hepatitis B (HBV) belum dapat menjamin donor darah bebas dari HBV sehingga darah donor belum memenuhi persyaratan untuk ditransfusikan. Darah donor yang akan ditranfusikan hendaklah memenuhi syarat diantaranya
Susila Sastri
doaj   +1 more source

Result analysis of serology test and NAT quantitative detection of HBV DNA reactive blood donors

Zhongguo shuxue zazhi, 2022
Objective To investigate the related viral markers of HBV DNA reactive samples among voluntary blood donors in Shiyan area, so as to provide some reference for donor re-entry. Methods From August 2019 to June 2021, 78 samples with HBV DNA reactivity from
Shengnan WEI, Dongju PENG, Fang TIAN
doaj   +1 more source

Renyi generalizations of the conditional quantum mutual information [PDF]

, 2015
The conditional quantum mutual information $I(A;B|C)$ of a tripartite state $\rho_{ABC}$ is an information quantity which lies at the center of many problems in quantum information theory.
Accardi L., Dupuis F., Kaushik P. Seshadreesan, Kim I. H., Mario Berta, Mark M. Wilde, Uhlmann A.   +6 more
core   +2 more sources

Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk

Viruses, 2022
The efficacy of different screening scenarios in reducing hepatitis B virus (HBV) transmission risk as compared to the risk without screening was modeled in 9,337,110 donations from four geographical regions that had been subjected to hepatitis B surface
Nico Lelie, Michael Busch, Steven Kleinman   +2 more
doaj   +1 more source

New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation [PDF]

, 2016
open5noThe hepatitis B virus (HBV) infects more than 260 million people globally, with increasing incidence, especially in developing countries.
Bortoluzzi, Ilaria, Burra, Patrizia, Ferrarese, Alberto, Russo, Francesco Paolo, Zanetto, Alberto   +4 more
core   +1 more source

“Anti-HBc alone” in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients

World Journal of Gastroenterology, 2009
Hepatitis B virus (HBV) infection is endemic in various parts of the world. A proportion of patients have resolved prior exposure to HBV, as evidenced by the clearance of circulating hepatitis B surface antigen and the appearance of antibody to hepatitis B core antigen (anti-HBc), which could produce protective antibody to hepatitis B surface antigen ...
Yu Xuan Koo, Daniel SW Tan, Iain BH Tan, Richard Quek, Miriam Tao, Soon Thye Lim   +5 more
openaire   +1 more source

Clinical significance of isolated anti-HBc positivity in cases of chronic liver disease in New Delhi, India

Journal of Global Infectious Diseases, 2009
Background: The presence of anti-HBc IgG in the absence of HBsAg is usually indicative of a past self-limiting HBV infection. But it is frequently associated with co-infection with HCV which can worsen the existing status of chronic liver disease (CLD).
Manisha Jain, Anita Chakravarti, P Kar
doaj   +1 more source

Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients

Frontiers in Immunology, 2022
Background and aimsPrecise predictors are lacking for hepatitis B surface antigen (HBsAg) clearance under the combination therapy of nucleos(t)ide analogs (NA) and pegylated interferon-alpha (PEG-IFN-α) in patients with chronic hepatitis B (CHB).
Wen-Xin Wang, Wen-Xin Wang, Wen-Xin Wang, Rui Jia, Rui Jia, Ying-Ying Gao, Jia-Ye Liu, Jun-Qing Luan, Fei Qiao, Li-Min Liu, Xiao-Ning Zhang, Fu-Sheng Wang, Fu-Sheng Wang, Fu-Sheng Wang, Junliang Fu, Junliang Fu, Junliang Fu   +16 more
doaj   +1 more source

Molecular investigation of occult hepatitis B virus infection in a reference center in Northern Brazil

Brazilian Journal of Infectious Diseases, 2022
The goal of this study was to investigate the prevalence of occult HBV infection in a reference center for the Northern Brazil from 2005 to 2015 and to identify mutations associated with occult hepatitis B.
Suellen dos Reis Araújo, Andreza Pinheiro Malheiros, Vânia Pinto Sarmento, Heloisa Marceliano Nunes, Pedro Eduardo Bonfim Freitas   +4 more
doaj   +1 more source